True, and going along with what Pixel said, while they may not get kickbacks directly, the patients continual return guarantees their practice…
And while direct kickbacks are illegal in many places, it does still happen. Just because it’s illegal doesn’t mean no one does it, as with anything else illegal that many people do anyways, even despite knowing the risks…
And while not a direct kickback per prescription, this stuff shows there is a financial incentive… basically, advertise my pill and I’ll pay you…Note here it says they are paid for ‘promotional talks’
In recent years, drug companies have started releasing details of the payments they make to doctors and other health professionals for promotional talks, research and consulting. As of 2013, 17 companies published the information, most because of legal settlements.
Where do you think they get all those nice big framed ads for pills like Abilify and Latuda you see in a lot of psych clinics?
And here, like i said, despite that it’s illegal…
According to the federal lawsuit, Reinstein routinely prescribed anti-psychotic and other psychiatric medications to his patients based, not on their need but on his receipt of kickbacks from pharmaceutical companies.
Reinstein routinely prescribed Clozaril, the trade name for clozapine manufactured by Novartis, and he often had more than 1,000 patients using the medication at any given time, the lawsuit state. For many years, Novartis paid Reinstein to promote Clozaril, it alleges.
In July 2003, Novartis notified Reinstein that it would be withdrawing its support for Clozaril, and ended the regular payments that it had been making to Reinstein.
In August 2003, the lawsuit says Reinstein offered to switch his patients to generic clozapine manufactured by Ivax Pharmaceuticals if the company met several conditions: Agree to pay Reinstein $50,000 under a one-year “consulting agreement”; pay his nurse to speak on behalf of clozapine; and fund a clozapine research study by a Reinstein-affiliated entity known as Uptown Research Institute.
Ivax agreed and Reinstein immediately began switching his patients from Clozaril to Ivax’s clozapine, according to the lawsuit, which noted that he “quickly became the largest prescriber of generic clozapine in the country.”